Dramatic Increase in Response With Combination for Relapsed/Resistant ITP

Responses in 80%, sustained in 61% with all-trans retinoic acid and low-dose rituximab

Related Keywords

Beijing ,China ,New York ,United States ,Newyork Presbyterian Hospital ,Peking ,Chinese ,Xiao Jun Huang ,Charles Bankhead ,Eun Ju Lee ,Jamesb Bussel ,University People Hospital ,Peking University People ,Medpage Today ,Titp ,Rituximab ,Retinoic Acid ,Bleeding ,Danazol ,